Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8051
Peer-review started: May 18, 2021
First decision: June 15, 2021
Revised: June 29, 2021
Accepted: August 5, 2021
Article in press: August 5, 2021
Published online: September 26, 2021
Cardiogenic cerebral infarction is an important pathological type of cerebral infarction.
The difference between direct mechanical thrombectomy and bridging therapy in treating cerebral infarction with anterior circulation macrovascular occlusion still needs to be further explored and confirmed.
This study aimed to investigate the efficacy and safety of bridging therapy and direct mechanical thrombectomy in the treatment of cardiogenic cerebral infarction with anterior circulation macrovascular occlusion.
Total 96 patients with cardiogenic cerebral infarction with anterior circulation macrovascular occlusion were retrospectively selected and divided into a direct thrombectomy group and a bridging group according to the treatment plan.
There was no significant difference in the recanalization rate between the direct thrombectomy group and the bridging group.
Bridging therapy and direct mechanical thrombectomy for the treatment of cardiogenic cerebral infarction with anterior circulation macrovascular occlusion can achieve good vascular recanalization effects and improve the prognosis and neurological function of patients.
Whether the research results can be broadly generalized still needs to be further investigated and confirmed by expanding the sample selection range and increasing the sample size.